Cellworks Omics Biology Model (CBM) to identify amplifications of chromosome 11p and 1p predict paclitaxel and carboplatin resistance.

Michael Castro,Ansu Kumar,Himanshu Grover,Vivek Patil,Prashant Nair,Srushti P Chafekar,Rakhi Purushothaman Suseela,Samiksha Avinash Prasad,Chandan Kumar,Vishwas Joseph,Nirjhar Mundkur,Pallavi Kumari,Anusha Pampana,Vijayashree P S,Ashish Choudhary,Veena Balakrishnan,Zakir Husain,Ashokraja Balla,Naga Ganesh,Vamsidhar Velcheti

Cellworks Omics Biology Model (CBM) to identify amplifications of chromosome 11p and 1p predict paclitaxel and carboplatin resistance.

2021

e21208Background: Paclitaxel and carboplatin (PC) is used to treat a wide variety of malignancies including gynecologic, breast, lung, and occult primary cancers. In NSCLC, PC led to a substantial ...

Keywords:

Paclitaxel
Medicine
Cancer research
Omics
Carboplatin
Chromosome

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations